Conference
First-Line Monotherapy With Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Advanced Non-Small Cell Lung Cancer (NSCLC): Safety, Efficacy, and Correlation of Outcomes With PD-L1 Status Metastatic Non-Small Cell Lung Cancer
Authors
Rizvi NA; Shepherd FA; Antonia SJ; Brahmer JR; Chow LQ; Goldman J; Juergens R; Borghaei H; Ready NE; Gerber DE
Volume
90
Publisher
Elsevier
Publication Date
November 15, 2014
DOI
10.1016/j.ijrobp.2014.08.204
Conference proceedings
International Journal of Radiation Oncology • Biology • Physics
Issue
5
ISSN
0360-3016